ROMIPLOSTIM and DRUG INEFFECTIVE

Overview

DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for ROMIPLOSTIM, manufactured by Amgen, Inc. There are 1,700 FDA adverse event reports linking ROMIPLOSTIM to DRUG INEFFECTIVE. This represents approximately 7.0% of all 24,148 adverse event reports for this drug.

Patients taking ROMIPLOSTIM who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG INEFFECTIVE1,700 of 24,148 reports

DRUG INEFFECTIVE is moderately reported among ROMIPLOSTIM users, representing a notable but not dominant share of adverse events.

Other Side Effects of ROMIPLOSTIM

In addition to drug ineffective, the following adverse reactions have been reported for ROMIPLOSTIM:

PLATELET COUNT DECREASED — 1,689 reports
OFF LABEL USE — 1,164 reports
DEATH — 989 reports
THERAPEUTIC RESPONSE DECREASED — 942 reports
PLATELET COUNT ABNORMAL — 939 reports
THROMBOCYTOPENIA — 930 reports
HEADACHE — 582 reports
FATIGUE — 455 reports
HAEMORRHAGE — 374 reports
PLATELET COUNT INCREASED — 373 reports

Other Drugs Associated with DRUG INEFFECTIVE

The following drugs have also been linked to drug ineffective in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABATACEPT ABEMACICLIB ABIRATERONE ACETATE ACETAMINOPHEN ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE

Does ROMIPLOSTIM cause DRUG INEFFECTIVE?

DRUG INEFFECTIVE has been reported as an adverse event in 1,700 FDA reports for ROMIPLOSTIM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG INEFFECTIVE with ROMIPLOSTIM?

DRUG INEFFECTIVE accounts for approximately 7.0% of all adverse event reports for ROMIPLOSTIM, making it one of the most commonly reported side effect.

What should I do if I experience DRUG INEFFECTIVE while taking ROMIPLOSTIM?

If you experience drug ineffective while taking ROMIPLOSTIM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.